Neuro-fuzzy technology as a predictor of parathyroid hormone level in hemodialysis patients

Chiou An Chen, Yu Chuan Li, Yuh Feng Lin, Fu Chiu Yu, Wei Hsin Huang, Jainn Shiun Chiu

研究成果: 雜誌貢獻文章

4 引文 斯高帕斯(Scopus)

摘要

Measuring the plasma parathyroid hormone (PTH) concentration is crucial to evaluate renal bone disease in patients with renal failure. Although frequent measurement is needed to avoid inadequate prescription of phosphate binders and vitamin D preparations, artificial intelligence can repeatedly perform the forecasting tasks and may be a satisfactory substitute for laboratory tests. Neurofuzzy technology represents a promising forecasting application in clinical medicine. We therefore constructed a coactive neuro-fuzzy inference system (CANFIS) to predict plasma PTH concentrations in hemodialysis patients. The CANFIS was constructed with clinical parameters (patient age, plasma albumin, calcium, phosphorus, alkaline phosphatase, and calcium-phosphorus product) from a cohort of hemodialysis patients, and plasma PTH concentration measured by radioimmunoassay (RIA) was the supervised outcome. The accuracy of the CANFIS was prospectively compared with RIA in another hospital. Plasma PTH concentrations measured by RIA and predicted by CANFIS were 179.04 ± 38.18 ng/l and 179.34 ± 37.76 ng/l, respectively (p = 0.15). The CANFIS was able to precisely estimate plasma PTH concentrations in hemodialysis patients. These results suggest that the neuro-fuzzy technology, based on limited clinical parameters, is an excellent alternative to RIA for accurately predicting plasma PTH concentration in hemodialysis patients.

原文英語
頁(從 - 到)81-87
頁數7
期刊Tohoku Journal of Experimental Medicine
211
發行號1
DOIs
出版狀態已發佈 - 2007
對外發佈Yes

ASJC Scopus subject areas

  • Medicine(all)

指紋 深入研究「Neuro-fuzzy technology as a predictor of parathyroid hormone level in hemodialysis patients」主題。共同形成了獨特的指紋。

引用此